...
首页> 外文期刊>Journal of Parasitology Research >Antiplasmodial and Cytotoxic Activities of Extracts of Selected Medicinal Plants Used to Treat Malaria in Embu County, Kenya
【24h】

Antiplasmodial and Cytotoxic Activities of Extracts of Selected Medicinal Plants Used to Treat Malaria in Embu County, Kenya

机译:肯尼亚Embu县疟疾治疗疟疾的抗癌和细胞毒性活动

获取原文

摘要

Malaria is a deadly disease caused by a protozoan parasite whose mode of transmission is through a female Anopheles mosquito. It affects persons of all ages; however, pregnant mothers, young children, and the elderly suffer the most due to their dwindled immune state. The currently prescribed antimalarial drugs have been associated with adverse side effects ranging from intolerance to toxicity. Furthermore, the costs associated with conventional approach of managing malaria are arguably high especially for persons living in low-income countries, hence the need for alternative and complementary approaches. Medicinal plants offer a viable alternative because of their few associated side effects, are arguably cheaper, and are easily accessible. Based on the fact that studies involving antimalarial medicinal plants as potential sources of efficacious and cost-effective pharmacotherapies are far between, this research was designed to investigate antiplasmodial and cytotoxic activities of organic and aqueous extracts of selected plants used by Embu traditional medicine practitioners to treat malaria. The studied plants included Erythrina abyssinica (stem bark), Schkuhria pinnata (whole plant), Sterculia africana (stem bark), Terminalia brownii (leaves), Zanthoxylum chalybeum (leaves), Leonotis mollissima (leaves), Carissa edulis (leaves), Tithonia diversifolia (leaves and flowers), and Senna didymobotrya (leaves and pods). In vitro antiplasmodial activity studies of organic and water extracts were carried out against chloroquine-sensitive (D6) and chloroquine-resistance (W2) strains of Plasmodium falciparum. In vivo antiplasmodial studies were done by Peter’s four-day suppression test to test for their in vivo antimalarial activity against P. berghei. Finally, cytotoxic effects and safety of the studied plant extracts were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) rapid calorimetric assay technique. The water and methanolic extracts of T. brownii and S. africana and dichloromethane extracts of E. abyssinica, S. pinnata, and T. diversifolia leaves revealed high in vitro antiplasmodial activities (IC50≤10?μg/ml). Further, moderate in vivo antimalarial activities were observed for water and methanolic extracts of L. mollissima and S. africana and for dichloromethane extracts of E. abyssinica and T. diversifolia leaves. In this study, aqueous extracts of T. brownii and S. africana demonstrated high antiplasmodial activity and high selectivity indices values (SI≥10) and were found to be safe. It was concluded that T. brownii and S. africana aqueous extracts were potent antiplasmodial agents. Further focused studies geared towards isolation of active constituents and determination of in vivo toxicities to ascertain their safety are warranted.
机译:疟疾是由原生动物寄生虫引起的致命疾病,其传播方式通过雌性粪便蚊子。它会影响所有年龄段的人;然而,由于其Dwindled的免疫状态,怀孕的母亲,幼儿和老年人遭受了最多的苦难。目前规定的抗疟药药物与不耐受性与毒性的不良副作用有关。此外,与管理疟疾的常规方法相关的成本可以说是高度高收入国家的人,因此需要替代和互补方法。药用植物由于少数相关的副作用而提供可行的替代品,可以说是更便宜的,并且易于访问。基于涉及抗疟药植物作为潜在有效和经济高效的药物医疗的潜在来源的研究甚远,该研究旨在研究embu传统医学从业者使用的抗癌和水性提取物的抗溶酶和细胞毒性活性疟疾。学习的植物包括erythrina abyssinica(Stem Bark),Schkuhria Pinnata(整株植物),斯特鲁里亚非洲人(Stew Bark),常年棕榈(叶子),zanthoxylum chalybeum(叶子),leonotis mollissima(叶子),carissa edulis(叶子),tithonia Diversifolia(叶子和花)和塞纳·迪摩博丁兰(叶子和豆荚)。在氯喹敏感(D6)和氯喹抗(W2)疟原虫菌株的体外抗溶液活性研究进行有机和水提取物。在体内抗蛋白酶研究通过Peter的为期为抑制试验来测试它们对P. Berghei的体内抗疟疾活动。最后,使用3-(4,5-二甲基噻唑-2-基-2-基)-2,5-二苯基四唑溴铵(MTT)快速量热测定技术评估研究的植物提取物的细胞毒性效应和安全性。 T.Brownii和S. Afferana和S. Affaca和Dichloromethane提取物的水和甲醇萃取物。欧洲葡萄球菌和T.0叶片的Diversifolia叶片揭示了高体外抗蛋白酶(IC50≤10Ω·μg/ ml)。此外,观察到L.Mollissima和S. Afferana的水和甲醇萃取物和E. abyssinica和T. diversifolia叶子的水和甲烷提取物中适度的体内抗疟疾活性。在该研究中,T.Brownii和S. Africana的水性提取物证明了高抗癌症活性和高选择性指数值(Si≥10),并且被发现是安全的。结论是,T.Brownii和S. Africana水性提取物是有效的抗蛋白剂。需要进一步聚焦研究,旨在分离活性成分和测定体内毒性以确定其安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号